The Patent Finder

EIP Pharma, LLC

8 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Compositions and methods for treating dementia (US 10,420,770) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

PatentTitleStatus Expires Confidence
US 8,697,627Compositions and methods for treating alzheimer's disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,427,438Compositions and methods for treating Alzheimer's disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,579,322Methods for treating neurologic disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,427,439Methods and compositions for recovery from stroke
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,420,770Compositions and methods for treating dementia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,466,008Co-crystals of neflamapimod (VX-745)
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,653,695Pharmaceutical formulations of neflamapimod
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,734,174Treatment of a Selective Population of Patients Having Dementia with Lewy Bodies
In force
 · Medium confidence
In forceMedium confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 4 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/707,318Treatment of a Selective Population of Patients Having Dementia with Lewy BodiesNov 4, 2022Pending
17/572,896Compositions and Methods for Treating Basal Forebrain DiseaseJan 11, 2022Pending
18/035,543Nov 5, 2021No status recorded
17/102,759Nov 24, 2020No status recorded
17/761,703Compositions and Methods for Treating Prion DiseaseSep 18, 2020Abandoned
16/549,645Aug 23, 2019No status recorded
14/191,984Feb 27, 2014No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited